INCY

$127.81 1.08% $1.36
Aug 21, 2026 04:00 AM

INCY stands for Incyte Corporation, a biopharmaceutical company focused on developing novel medicines.

Scroll or pinch to zoom · drag to pan the chart

Updating chart…

Price chart bar size:

Share on:

Asset Summary

Loading summary…

Asset Performance Metrics and Risk Characteristics:

Metrics below use daily returns for Jan 1, 2026 – Aug 23, 2026 (YTD).

Understanding asset performance is crucial for evaluating investment quality and making informed decisions. Metrics like trailing return and drawdown provide insights into how an asset has performed over time, its volatility, and the efficiency of its returns relative to risk. Performance indicators help assess the stability, risk, and reward of an investment, allowing investors and portfolio managers to make comparisons and strategize accordingly.

Asset Technical Analysis

Technical analysis involves evaluating an asset's price and volume data to forecast future movements and make informed trading decisions. Using indicators such as moving averages, pivot levels, momentum studies, and candlestick pattern scans can clarify trend strength and volatility. The tabs below summarize moving averages, pivots, technical indicators, candlestick patterns, and recent prices for this symbol.

Analysis

Moving Averages

Moving Averages are commonly used to smooth out price data and identify trends over a specific period. Here’s a summary of the latest moving averages for various periods:

  • SMA (Simple Moving Average): Reflects the average price over a specific number of periods.
  • EMA (Exponential Moving Average): Gives more weight to recent prices, making it more responsive to new information.
  • WMA (Weighted Moving Average): Assigns a weight to each price, emphasizing more recent prices.
  • WEMA (Weighted Exponential Moving Average): Combines elements of both WMA and EMA for a more responsive moving average.

Unleash Your INCY Trading Now

Revolutionize your investment in INCY with OHLCX Platform’s innovative trading solutions. Benefit from our comprehensive risk management features and sophisticated price analysis tools. Transform your trading strategy now with OHLCX Platform now and achieve better trading outcomes!

Get Advanced Analysis Now

Frequently Asked Questions

Incyte is headquartered in Wilmington, Delaware, USA.

Incyte partners with other pharmaceutical companies and academic institutions to enhance its research capabilities.

Incyte offers additional therapies for various conditions, including ruxolitinib for myelofibrosis and graft-versus-host disease.

Incyte engages with patient communities to provide support and educational resources about their conditions and treatments.

Incyte employs a science-driven approach, focusing on molecularly targeted therapies to address unmet medical needs.

Yes, Incyte is heavily invested in R&D to discover and develop new therapies for serious diseases.

Investors can visit Incyte’s official website for detailed information on financial performance and corporate updates.

Jakafi works by inhibiting specific enzymes involved in cell signaling pathways that contribute to cancer.

Incyte’s mission is to innovate and deliver therapies that improve the lives of patients with serious diseases.

Incyte’s flagship product is Jakafi (ruxolitinib), used to treat certain types of blood cancer.

Supercharge Your INCY Trading Now

Achieve superior trading results with OHLCX.com. Our platform provides expert analysis and actionable insights for INCY, utilizing the latest technology to refine your investment approach. Start optimizing your trades today now and see the impact on your trading success!

Disclaimers

The information displayed on this site is sourced from third-party providers and is believed to be reliable. OHLCX has not independently verified this data and does not guarantee its accuracy. Content is for educational and informational purposes only and is not financial or investment advice.

With any investment, your capital is at risk. Past performance is no guarantee of future results. Consult your provider's terms and privacy policies where applicable.

Market data is provided in near real-time when available, but we do not guarantee its accuracy or timeliness.

Securities products are: Not FDIC insured · Not bank guaranteed · May lose value

Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind.